Report Says 40,000+ Minnesotans Will Save on Medicare Prescriptions

August 29, 2024

On August 28, AARP released a report that shows an estimated 40,050 of Minnesotans on Medicare prescription drug plans will see savings thanks to a new out-of-pocket cap that starts January 1, 2025.  

The savings are made possible by a provision in the 2022 prescription drug law that AARP championed that caps out-of-pocket prescription drug costs every year, beginning at $2,000 next year, for America’s 56 million Medicare drug plan enrollees. 

The AARP report analyzes the number of enrollees who will benefit from the cap by state, age, gender, and race between 2025 and 2029. The findings indicate that Medicare drug plan enrollees nationwide who reach the new out-of-pocket cap will see average savings of roughly $1,500, or 56%, in 2025 for their prescription drugs.  

Other findings from the report include: 

  • Between 3 and 4 million Part D plan enrollees nationwide are estimated to benefit from the new out-of-pocket cap every year between 2025 and 2029, which equals 40,050 in Minnesota. 

  • More than three-quarters of Medicare drug plan enrollees who will benefit in 2025 are between the ages of 65 and 84. 

AARP Minnesota serves more than 620,000 members age 50 and older in the state.   

Latest News

MMA Opposes CMS Proposed Rule that Restricts Medicaid Provider Taxes

July 16, 2025

On July 8, the MMA submitted a formal comment in opposition to a Centers for Medicare and Medicaid Services (CMS) proposed rule that would dramatically restrict states’ ability to impose Medicaid provider taxes on insurance companies. 

AG Ellison Discusses Work to Protect Patients and Healthcare Affordability with MMA Board

July 16, 2025

Minnesota Attorney General Keith Ellison met with the MMA Board of Trustees at its July 14 meeting and offered to regularly engage with the group to discuss the state’s healthcare issues.  

DEA Warns: New Scam Letters and Calls Target Medical Practitioners

July 16, 2025

The Drug Enforcement Administration (DEA) is warning its registrants of new fraud schemes in which scammers impersonate DEA personnel and notify them that they are under investigation, presumably to obtain personal information.